Brain Cancer Trial, Recruiting (NCT03526822)

Brain Cancer Trial, Recruiting NCT03526822 Sponsor: Assistance Publique Hopitaux De Marseille Condition: Brain Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT03526822 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Brain Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older, either male or female
Your brain scans suggest you may have glioblastoma (a type of brain tumor)
Your doctors have determined you are suitable for surgery to remove the tumor (fully or partially)
You are planned to receive the standard combined treatment of radiation therapy and chemotherapy after surgery (known as the Stupp protocol)
You have signed a consent form agreeing to take part in the trial
You have had an MRI scan before your surgery

Who may not be able to join:

You are unable to have an MRI scan for medical reasons (for example, having a pacemaker or metal implants)
Your tumor cannot be treated with surgery
You have previously had radiation therapy or chemotherapy for this particular brain tumor
Your tumor appears to be a slower-growing, lower-grade type (confirm with trial site)
You are in an emergency situation, are under legal guardianship, or are unable to give your own consent
You are not covered by a social security or health insurance scheme (confirm with trial site)
You are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jean-Olivier ARNAUD, Director, Assistance Publique Hôpitaux de Marseille

Phone: 491385500

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03526822

Sponsor: Assistance Publique Hopitaux De Marseille

Phase: Not Applicable

Status: Recruiting

Condition: Brain Cancer

Trial contact: 491385500

More information: https://clinicaltrials.gov/study/NCT03526822

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older, either male or female
Your brain scans suggest you may have glioblastoma (a type of brain tumor)
Your doctors have determined you are suitable for surgery to remove the tumor (fully or partially)
You are planned to receive the standard combined treatment of radiation therapy and chemotherapy after surgery (known as the Stupp protocol)
You have signed a consent form agreeing to take part in the trial
You have had an MRI scan before your surgery

Who may not be able to join:

You are unable to have an MRI scan for medical reasons (for example, having a pacemaker or metal implants)
Your tumor cannot be treated with surgery
You have previously had radiation therapy or chemotherapy for this particular brain tumor
Your tumor appears to be a slower-growing, lower-grade type (confirm with trial site)
You are in an emergency situation, are under legal guardianship, or are unable to give your own consent
You are not covered by a social security or health insurance scheme (confirm with trial site)
You are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Assistance Publique Hopitaux De Marseille

Registry

ClinicalTrials.gov

Start date

2 July 2018

Est. completion

1 January 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

correlate the plasma levels of MMP2 and MMP9 to their RNA and protein tissue expression by ELISA

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov